The layoffs first started last month, when Tesla began laying off what was said to be at the time 10 percent of the company’s ...
Swiss drugmaker Sandoz launched its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira biosimilar to hit the U.S. market, priced at a 5% and 55% ...
The drug-pricing watchdogs over at the Institute for Clinical and Economic Review tend to be supportive of gene therapy ...
Electric-vehicle maker Tesla has launched another round of layoffs including staff from the software, service and engineering ...
As with Epogen, the initial discoveries that laid the basis for the drug had ... That decade of investment and research was paying off. In 1992, Amgen hit the billion dollars sales mark and ...
Chroma Medicine laid off an undisclosed number of employees ... Sandoz reached an agreement with Amgen to resolve all patent ...
In this edition of Week in Review (WiR), we recap Google's recent layoffs -- and Tesla's -- and the UnitedHealthcare hacks.
Tesla laid off multiple teams in the latest cuts made after announcing a 10% reduction in employees earlier this month. The ...
April 4 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due ... with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira ...
(Adds Boehringer comment in paragraphs 4 and 5 of April 4 story) By Patrick Wingrove April 5 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to ...